|Printable version||E-mail this to a friend|
European Union Agency for Railways launches Safety Alert IT tool
The European Union Agency for Railways, in an effort to increase transparency in rail safety incident reporting in the EU, and to share information among rail operators and manufacturers, launched a Safety Alert IT tool at the InnoTrans fair in Berlin.
Building trust among market participants, sharing information and lessons learned are the guiding principles of the Safety Alert IT tool (SAIT). The tool will facilitate timely sharing of information on significant risks relating to technical equipment, supporting other actors to take immediate action to avoid accidents.
“In a shared European railway system, with a diverse set of players, transparency and shared lessons in incident reporting are vital for making Europe the world leader in rail safety”, said Josef Doppelbauer, Executive Director of the European Union Agency for Railways. “It is an important building block for creating a positive safety culture in Europe.”
The SAIT is the first deliverable of the Agency in the framework of the Technical Pillar of the 4th Railway package. It will initially be available in three languages (EN, FR, DE), with more language versions being added in the coming years . It can be used on portable devices and shares information in real time.
Please click here to download the press release.
Please click to reach Safety Alerts IT Tool.
Latest News from
First ever guidance for stem cell therapies in animals published26/06/2017 13:10:00
Document gives advice on sterile manufacturing processes for veterinary stem cell medicines.
EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome26/06/2017 12:44:00
A review by the EMA has concluded that Symbioflor 2 and associated names can continue to be used for treatment of irritable bowel syndrome (IBS) in adults. However, the medicine should no longer be used more widely to treat so-called functional gastrointestinal disorders.
Two new medicines recommended for the treatment of chronic hepatitis C26/06/2017 11:53:00
The European Medicines Agency has recommended granting marketing authorisations in the EU for Maviret and Vosevi, two new medicines indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Cities and regions key to strengthen economic recovery and undertake structural reforms, new report shows23/06/2017 16:20:00
The role of local and regional authorities and the awareness of territorial concerns in addressing economic challenges are growing. This is the conclusion of a new analysis by the European Committee of the Regions (CoR) showing that 75% of the Country-specific Recommendations are related to the territory.